Disease: Colorectal Cancer  
Disease: colorectal carcinoma  
OrganismPart: colon tissue  
NumberOfSamples: n=30  
NumberOfSamples: n=19  
NumberOfSamples: n=35  
NumberOfSamples: n=20  
Age: 69 years  
Age: 27-85 years  
Sex: women  
Sex: men  
TumorSite: caecum  
TumorSite: colon  
TumorSite: sigma  
TumorSite: rectum  
Age: 62 years  
Age: 24-82 years  
NumberOfSamples: n=50  
NumberOfSamples: n=15  
MaterialType: Peripheral blood mononuclear cells (PBMC)  
Separation: density gradient centrifugation  
AssayName: HLA-typing  
AssayName: LUMINEX  
AssayName: sequence-based typing  
AssayName: molecular HLA-typing  
EnrichmentMethod: immunoaffinity purification  
Bait: panHLA-class I monoclonal antibody W6/32  
Bait: HLA-DR monoclonal antibody L243  
Bait: panHLA-class II monoclonal antibody Tü39  
SampleTreatment: 0.2% trifluoroacetic acid  
AssayName: LC-MS/MS  
Instrument: UltiMate 3000 RSLCnano System  
Separation: nanoflow uHPLC  
Instrument: LTQ Orbitrap XL mass spectrometer  
GradientTime: 90 minutes  
FragmentationMethod: collision-induced dissociation  
SourceName: Swiss-Prot database  
Modification: Oxidized methionine  
SourceName: in-house database of HLA-ligandome data from 132 non-malignant tissues  
SupplementaryFile: PXD009602  
AssayName: KEGG pathway analysis  
AssayName: PANTHER  
AssayName: label-free quantitation  
Instrument: Lab Vision Autostainer  
Staining: HLA-class I  
Staining: HLA-class II  
Instrument: EPS 221  
Instrument: ABI 433A  
Modification: Fmoc/tBu  
Instrument: FACSCanto  
AssayName: IFN-γ ELISpot  
AssayName: multimer staining  
Treatment: IL-12  
Treatment: IL-2  
Compound: LSM 1077  
Compound: trifluoroacetic acid